Syllabus · Current · V5 (2025) · Respiratory System
C10 · Respiratory Pharmacology and Equipment
C10.iv · Inhaled Pulmonary Vasodilators
Understand the pharmacology of inhaled pulmonary vasodilator drugs.
Written examination
SAQ history
Pulmonary Vasodilators — Inhaled Agents
2 exam appearances
Describe the mechanisms of action and potential adverse effects of inhaled nitric oxide and prostacyclin.
15%
Describe the mechanism of action, and adverse effects, of pulmonary vasodilators that are administered via the inhalational route.
8%
Pulmonary Vasodilators — Nitric Oxide
1 exam appearance
Pulmonary Vasoconstriction & Inhaled Vasodilators
1 exam appearance
a) Describe the physiological factors that contribute to pulmonary vasoconstricton. Include the mechanisms involved in your answer (60% of marks). b) For each of the inhaled pulmonary vasodilators, nitric oxide and prostacyclin: i) describe the mechanism(s) of action (25% of marks) ii) outline the adverse effects (15% of marks).
44.6%
Oral examination
VIVA history
No mapped VIVA history for this objective.
Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.